Senores Pharmaceuticals informs about disclosure

30 Jul 2025 Evaluate
Senores Pharmaceuticals has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Renosen Pharmaceuticals.

The above information is a part of company’s filings submitted to BSE.

Senores Pharmaceutic Share Price

795.20 7.85 (1.00%)
01-Feb-2026 13:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1617.70
Dr. Reddys Lab 1214.65
Cipla 1316.50
Zydus Lifesciences 884.00
Lupin 2119.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×